News Headlines Article

High-cost drugs: California legislator pulls bill seeking cost ‘transparency’
Contra Costa Times

In a surprising last-minute move, the Bay Area lawmaker carrying legislation to increase the “transparency” of prescription drug costs in California on Tuesday pulled his bill off the Assembly Health Committee agenda, saying he didn’t have the votes.

But Assemblyman David Chiu, D-San Francisco, promised to be back “because this issue will not go away.”

Assembly Bill 463 would require each manufacturer of a prescription drug sold in California with a wholesale cost of $10,000 or more per course of treatment to report “select information” such as research and development costs, marketing and advertising costs, and company profits derived from the sale of the drug.